RxDoctor Payments Data

Christopher Hyer, DPM

Foot & Ankle Surgery · Worthington, OHNPI 1033185152

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $3,574,676 of the $4,722,190 with a category attached, or 75.7%. Stryker accounts for 62.7% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2022 at $926,990 and has fallen 57.7% since, to $391,878 in 2025. Among foot & ankle surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,722,190in general payments, 2019–2025

Across 1,104 payments — averaging $4277.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3M
  • Smith+Nephew$491K
  • Integra Lifesciences Corporation$337K
  • International Life Sciences$240K
  • Linvatec Corporation$207K
  • Zimmer Biomet$117K
  • plus $370K from 32 others
$93,185in research payments, 2019–2025

Across 39 payments — averaging $2389.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Globus Medical$38K
  • Vilex LLC$19K
  • Integra Lifesciences Corporation$17K
  • Smith+Nephew$13K
  • Biotissue Holdings Inc.$6K
$100,000in ownership & investment interests, 2019–2025

Across 9 payments — averaging $11,111 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$100K
  • In2bones USA, LLC$0

What the payments were for

  • Royalty or licence$3,574,67676%
  • Consulting fees$721,52715%
  • Speaking & faculty fees$141,1703%
  • Grants$5,0000%
  • Travel & lodging$79,6962%
  • Food & beverage$19,8840%
  • Education$4,0910%
  • Gifts$300%
  • Other$176,1164%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,722,190 in reported general payments places this provider in the 95th percentile of 429 foot & ankle surgery providers in Ohio.

See all foot & ankle surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$111,843
Medicare patients
199
Services billed
1,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone53$245
Celecoxib12$121
Meloxicam21$106

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Worthington

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →